Stock price information for Kringle Pharma,Inc., including nighttime PTS, and highlights from its latest results have been released. In results announced on 10 August 2026, sales rose substantially, but the company continued to report operating and net losses.
Kringle Pharma,Inc.'s detailed stock information shows a previous closing price of ¥430, an opening price of ¥430, a high of ¥434, a low of ¥418, trading volume of 95,200 shares and trading value of ¥40.692 million. The stated price limit is ¥350–¥510.
The results were announced on 10 August 2026. For the cumulative third quarter, net sales rose 501.0% year on year to ¥324 million, while the company continued to report an operating loss of ¥634 million and a net loss for the quarter of ¥632 million.
Performance over the past 12 quarters has been deteriorating, with net profit margin and EPS declining substantially. The equity ratio is relatively stable at 61.6%, but profitability has shown pronounced volatility.
IFIS Japan is listed as the source of the analyst forecasts.